Literature DB >> 10712200

Relaxation of insulin-like growth factor 2 imprinting and discordant methylation at KvDMR1 in two first cousins affected by Beckwith-Wiedemann and Klippel-Trenaunay-Weber syndromes.

M P Sperandeo1, P Ungaro, M Vernucci, P V Pedone, F Cerrato, L Perone, S Casola, M V Cubellis, C B Bruni, G Andria, G Sebastio, A Riccio.   

Abstract

Beckwith-Wiedeman syndrome (BWS) and Klippel-Trenaunay-Weber syndrome (KTWS) are different human disorders characterized, among other features, by tissue overgrowth. Deregulation of one or more imprinted genes located at chromosome 11p15.5, of which insulin-like growth factor 2 (IGF2) is the most likely candidate, is believed to cause BWS, whereas the etiology of KTWS is completely obscure. We report a case of BWS and a case of KTWS in a single family. The probands, sons of two sisters, showed relaxation of the maternal IGF2 imprinting, although they inherited different 11p15.5 alleles from their mothers and did not show any chromosome rearrangement. The patient with BWS also displayed hypomethylation at KvDMR1, a maternally methylated CpG island within an intron of the KvLQT1 gene. The unaffected brother of the BWS proband shared the same maternal and paternal 11p15.5 haplotype with his brother, but the KvDMR1 locus was normally methylated. Methylation of the H19 gene was normal in both the BWS and KTWS probands. Linkage between the insulin-like growth factor 2 receptor (IGF2R) gene and the tissue overgrowth was also excluded. These results raise the possibility that a defective modifier or regulatory gene unlinked to 11p15.5 caused a spectrum of epigenetic alterations in the germ line or early development of both cousins, ranging from the relaxation of IGF2 imprinting in the KTWS proband to disruption of both the imprinted expression of IGF2 and the imprinted methylation of KvDMR1 in the BWS proband. Analysis of these data also indicates that loss of IGF2 imprinting is not necessarily linked to alteration of methylation at the KvDMR1 or H19 loci and supports the notion that IGF2 overexpression is involved in the etiology of the tissue hypertrophy observed in different overgrowth disorders, including KTWS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10712200      PMCID: PMC1288167          DOI: 10.1086/302811

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  36 in total

1.  Involvement of IGF-II in human cancer.

Authors:  J A Toretsky; L J Helman
Journal:  J Endocrinol       Date:  1996-06       Impact factor: 4.286

2.  Imprinting mutation in the Beckwith-Wiedemann syndrome leads to biallelic IGF2 expression through an H19-independent pathway.

Authors:  K W Brown; A J Villar; W Bickmore; J Clayton-Smith; D Catchpoole; E R Maher; W Reik
Journal:  Hum Mol Genet       Date:  1996-12       Impact factor: 6.150

3.  Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour.

Authors:  M J Steenman; S Rainier; C J Dobry; P Grundy; I L Horon; A P Feinberg
Journal:  Nat Genet       Date:  1994-07       Impact factor: 38.330

4.  Klippel-Trenaunay-Weber syndrome associated with a 5:11 balanced translocation.

Authors:  A J Whelan; M S Watson; F D Porter; R D Steiner
Journal:  Am J Med Genet       Date:  1995-12-04

5.  DNA typing and genetic mapping with trimeric and tetrameric tandem repeats.

Authors:  A Edwards; A Civitello; H A Hammond; C T Caskey
Journal:  Am J Hum Genet       Date:  1991-10       Impact factor: 11.025

6.  Mono- and bi-allelic expression of insulin-like growth factor II gene in human muscle tumors.

Authors:  P V Pedone; R Tirabosco; A O Cavazzana; P Ungaro; G Basso; R Luksch; M Carli; C B Bruni; R Frunzio; A Riccio
Journal:  Hum Mol Genet       Date:  1994-07       Impact factor: 6.150

7.  Epigenetic changes encompassing the IGF2/H19 locus associated with relaxation of IGF2 imprinting and silencing of H19 in Wilms tumor.

Authors:  T Taniguchi; M J Sullivan; O Ogawa; A E Reeve
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-14       Impact factor: 11.205

8.  Disruption of imprinting caused by deletion of the H19 gene region in mice.

Authors:  P A Leighton; R S Ingram; J Eggenschwiler; A Efstratiadis; S M Tilghman
Journal:  Nature       Date:  1995-05-04       Impact factor: 49.962

9.  Somatic overgrowth associated with overexpression of insulin-like growth factor II.

Authors:  I M Morison; D M Becroft; T Taniguchi; C G Woods; A E Reeve
Journal:  Nat Med       Date:  1996-03       Impact factor: 53.440

10.  Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality.

Authors:  M M Lau; C E Stewart; Z Liu; H Bhatt; P Rotwein; C L Stewart
Journal:  Genes Dev       Date:  1994-12-15       Impact factor: 11.361

View more
  4 in total

1.  Epigenotype-phenotype correlations in Beckwith-Wiedemann syndrome.

Authors:  J R Engel; A Smallwood; A Harper; M J Higgins; M Oshimura; W Reik; P N Schofield; E R Maher
Journal:  J Med Genet       Date:  2000-12       Impact factor: 6.318

2.  Addition of H19 'loss of methylation testing' for Beckwith-Wiedemann syndrome (BWS) increases the diagnostic yield.

Authors:  Jochen K Lennerz; Robert J Timmerman; Dorothy K Grange; Michael R DeBaun; Andrew P Feinberg; Barbara A Zehnbauer
Journal:  J Mol Diagn       Date:  2010-07-08       Impact factor: 5.568

3.  Upregulation of IGF2 expression during vascular calcification.

Authors:  Dongxing Zhu; Neil C W Mackenzie; Jose Luis Millan; Colin Farquharson; Vicky E Macrae
Journal:  J Mol Endocrinol       Date:  2014-01-30       Impact factor: 5.098

4.  Management of Pregnancy with Klippel-Trenaunay-Weber Syndrome: A Case Report and Review.

Authors:  Rati Chadha
Journal:  Case Rep Obstet Gynecol       Date:  2018-07-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.